Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey

References

• Burt FJ, Leman PA, Smith JF, Swanepoel R. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo hemorrhagic fever. J Virol Methods 1998;70:129–37.
   PubMed Web of Science ®Google Scholar
• Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004;64:145–60.
   PubMed Web of Science ®Google Scholar
• Ergonul O, Whitehouse CA. Crimean-Congo hemorrhagic fever: a global perspective. Springer: Dordrecht, Netherlands 2007. 3–11.
   Google Scholar
• Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, . Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006;52:207–15.
   PubMed Web of Science ®Google Scholar
• Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H; the Turkish CCHF Study Group. Crimean-Congo hemorrhagic fever outbreak in Middle Anatolia: a multicenter study of clinical features and outcome measures. J Med Microbiol 2005;54:385–9.
   PubMed Web of Science ®Google Scholar
• Burt FJ, Swanepoel R, Shieh WJ, Smith FJ, Leman PA, Greer PW, . Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 1997;121:839–46.
   PubMed Web of Science ®Google Scholar
• Swanepoel R, Leman PA, Burt FJ, Jardine J, Verwoerd DJ, Capua I, . Experimental infection of ostriches with Crimean-Congo hemorrhagic fever virus. Epidemiol Infect 1998;121:427–32.
   PubMed Web of Science ®Google Scholar
• Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of IL-6, IL-10 and TNF-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006;193:941–4.
   PubMed Web of Science ®Google Scholar
• Karti S, Odabaşi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, . Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004;19:1379–84.
   Google Scholar
• Ministry of Health of Turkey. Reports of communicable diseases. Ankara, Turkey: Ministry of Health: 2006. Available at: http://www.saglik.gov.tr/KKKA/BelgeGoster.gov.tr (accessed April 2009).
   Google Scholar
• Peters CJ. California encephalitis. Hantavirus pulmonary syndrome and Bunyavirid hemorrhagic fevers. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. Churchill Livingstone: Philadelphia 2005. pp 2086–2090.
   Google Scholar
• Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iranian Med 2007;10:204–14.
   PubMed Web of Science ®Google Scholar
• Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, . The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis 2008;13:380–6.
   PubMedGoogle Scholar
• Yilmaz GR, Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, . A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March–June 2008. Eurosurveill 2008;13:pii:18953.
   Google Scholar
• Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006;6:203–14.
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean-Congo haemorrhagic fever treated with oral ribavirin. Lancet 1995;346:472–5.
   PubMed Web of Science ®Google Scholar
• Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analyses of risk factors among patients with Crimean-Congo hemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006;12:551–4.
   PubMed Web of Science ®Google Scholar
• Cevik MA, Erbay A, Bodur H, Gulderen E, Bastug A, Kubar A, . Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008;12:374–9.
   PubMed Web of Science ®Google Scholar
• Sharifi-Mood B, Matenat M, Ghorbani-Vaqhei A, Fayyaz-Jahani F, Akrami E. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med 2009;12:151–3.
   PubMed Web of Science ®Google Scholar
• Duh D, Nichol ST, Khristova ML, Saksida A, Hafner-Bratkovic I, Petrovec M, . The complete genome sequence of a Crimean-Congo hemorrhagic fever virus isolated from an endemic region in Kosovo. Virol J 2008;5:7.
   PubMedGoogle Scholar
• Jamil B, Hasan RS, Sarwari AR, Burton J, Hewson R, Clegg C. Crimean-Congo hemorrhagic fever: experience at a tertiary care hospital in Karachi, Pakistan. Trans R Soc Trop Med Hyg 2005;99:577–84.
   PubMed Web of Science ®Google Scholar
• Yen YC, Kong LX, Lee L, Zhang YQ, Li F, Cai BJ, . Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China. Am J Trop Med Hyg 1985;34:1179–82.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Crimean-Congo hemorrhagic fever. WHO fact sheet No. 208. Geneva: WHO; 2001.
   Google Scholar
• Shepherd AJ, Swanepoel R, Leman PA. Antibody response in Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11:801–6.
   PubMedGoogle Scholar
• Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, . Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect 2009;58:238–44.
   PubMedGoogle Scholar
• Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis 2009;28:929–33.
   PubMed Web of Science ®Google Scholar
• Izadi S, Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case control study. Jpn J Infect Dis 2009;62:11–5.
   PubMed Web of Science ®Google Scholar